Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimith-MF0.5 1000 SR Tablet

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (1000mg)

Overview Glimith-MF0.5 1000 SR Tablet

Diabetac-Duo 1000 SR, a dual-action antidiabetic medication, is prescribed for adult patients with type 2 diabetes. This combination therapy effectively manages blood glucose levels. Administer Diabetac-Duo 1000 SR with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a readily available fast-acting glucose source, like sugary snacks or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are essential.

Uses of Glimith-MF0.5 1000 SR Tablet

Managing type 2 diabetes

Major Benefits of Glimith-MF0.5 1000 SR Tablet:

Administer Glimith-MF0.5 1000 SR Tablet as prescribed by your physician, ingesting the entire tablet with food. Avoid chewing, crushing, or breaking the tablet. Dosage and treatment length should follow your doctor's instructions.

Common Side effects of Glimith-MF0.5 1000 SR Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimith-MF0.5 1000 SR Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimith-MF0.5 1000 SR Tablet with a meal.

How Glimith-MF0.5 1000 SR Tablet works:

Glimepiride/Metformin 0.5mg/1000mg extended-release tablets (Glimith-MF0.5 SR) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimith-MF0.5 1000 SR Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimith-MF0.5 1000 SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

The extended-release Glimith-MF0.5 1000 mg tablet is contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimith-MF0.5 1000 SR Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimith-MF0.5 1000 SR Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimith-MF0.5 1000 SR Tablet cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, it's contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimith-MF0.5 1000 SR Tablet :

Should you forget to take a Glimith-MF0.5 1000 SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimith-MF0.5 1000 SR Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimith-MF0.5 1000 SR Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glimith-MF0.5 1000 SR Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimith-MF0.5 1000 SR Tablet and seek immediate medical attention.
Glimith-MF0.5 1000 SR Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimith-MF0.5 1000 SR Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimith-MF0.5 1000 SR Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimith-MF0.5 1000 SR Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimith-MF0.5 1000 SR Tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimith-MF0.5 1000 SR Tab...
53
MRP 61
13% off